Popular Research on Digital Breast Tomosynthesis Market Report

Submitted by: Submitted by

Views: 112

Words: 1007

Pages: 5

Category: Business and Industry

Date Submitted: 06/16/2014 12:19 AM

Report This Essay

Digital Breast Tomosynthesis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Brest cancer is one of the most common cancers among women, with an estimate of about 500,000 mortalities in 2011 according to the World Health Organization (WHO). Although breast cancer is considered as a disease of developed countries, its prevalence is rising rapidly in the developing countries owing to urbanization and adoption of sedentary and stressful lifestyle. According to WHO, in 2012 an estimated of 70,000 females in India died due to breast cancer, while in China about 48,000 deaths were recorded and in the U.S. 44,000 deaths were recorded for breast cancer. The survival rate varies across the globe based on diagnosis time and rate along with the availability and affordability of services, with about 80% in North America and 60% in middle income countries. High prevalence globally has led doctors and scientists to take serious measures for early detection for the cancer so that proper care and treatment can be given to the patient. Developing technology is adding various innovative devices which have helped in early diagnosis of cancers. Digital breast tomosynthesis also referred to as 3D mammography, is one of the technologies being developed for detection and characterization of breast lesions. The technique involves multiple projection images which allow visualization of thin breast sections which reveals cancers buried within normal tissue, allowing better diagnosis of breast cancer. FDA approval of digital breast tomosynthesis, Selenia Dimensions System by Hologic, Inc. in 2011 has boosted the market. Quick adoption, fewer recalls and simultaneous market penetration supported the market growth. In 2013, GE received CE mark for SenoClaire, and entered the European market. The company also plans for regulatory approval in the U.S. Currently the digital breast tomosynthesis market has been more inclined towards North America and...